Search research articles
Contact Us
Filters
Showing results (91-100 of 105) with videos related to
Page
of 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 6, 2018
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition
Xian Chen, Kwang-Huei Low, Angela Alexander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 28, 2009
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer
Roshan Agarwal, Ana-Maria Gonzalez-Angulo, Simen Myhre, et al.
NPJ Breast Cancer
|
December 3, 2025
CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen
Nealia C House, Maxine M Chen, Sima Khazaei, et al.
Nature Communications
|
January 22, 2026
CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction
Linjie Luo, Yan Wang, Tuyen Bui, et al.
Pharmacological Reviews
|
March 27, 2025
Cell cycle dysregulation in cancer
Antonino Glaviano, Samarendra K Singh, E Hui Clarissa Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 24, 2005
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer
Astrid M Eder, Xiaomei Sui, Daniel G Rosen, et al.
BMC Genomics
|
February 21, 2018
Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes
Yuanxin Xi, Jiejun Shi, Wenqian Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 5, 2022
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring <i>CCNE1</i> Amplification
Siqing Fu, Shuyang Yao, Yuan Yuan, et al.
Leukemia
|
March 12, 2024
STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response
Bhakti Patel, Yifan Zhou, Rachel L Babcock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2019
Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer
Nicole M Kettner, Smruthi Vijayaraghavan, Merih Guray Durak, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 105) with videos related to
Sort By:
Page
of 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 6, 2018
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition
Xian Chen, Kwang-Huei Low, Angela Alexander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 28, 2009
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer
Roshan Agarwal, Ana-Maria Gonzalez-Angulo, Simen Myhre, et al.
NPJ Breast Cancer
|
December 3, 2025
CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen
Nealia C House, Maxine M Chen, Sima Khazaei, et al.
Nature Communications
|
January 22, 2026
CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction
Linjie Luo, Yan Wang, Tuyen Bui, et al.
Pharmacological Reviews
|
March 27, 2025
Cell cycle dysregulation in cancer
Antonino Glaviano, Samarendra K Singh, E Hui Clarissa Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 24, 2005
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer
Astrid M Eder, Xiaomei Sui, Daniel G Rosen, et al.
BMC Genomics
|
February 21, 2018
Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes
Yuanxin Xi, Jiejun Shi, Wenqian Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 5, 2022
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring <i>CCNE1</i> Amplification
Siqing Fu, Shuyang Yao, Yuan Yuan, et al.
Leukemia
|
March 12, 2024
STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response
Bhakti Patel, Yifan Zhou, Rachel L Babcock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2019
Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer
Nicole M Kettner, Smruthi Vijayaraghavan, Merih Guray Durak, et al.
Page
of 11